Pediatric endocrinology

Genotype-Treatment Correlations in Iranian Children with Congenital Hyperinsulinism: A Single-Center Cohort Study

Horm Res PaediatrPublished Observational cohort study

Authors' conclusion

Our findings demonstrate a significant correlation between genetic etiology and treatment response in children with CHI. Early genetic diagnosis may play a critical role in predicting therapeutic outcomes, guiding individualized treatment strategies, and avoiding unnecessary delays in definitive management. These results should be interpreted with caution given the small sample size and the rarity of certain genotypes.

Study context

Population
Neonates and children (1 week to 18 years) with biochemically confirmed congenital hyperinsulinism (CHI) and genetic testing by next-generation sequencing; median age at diagnosis 11 months (IQR: 5–42)33 analysed
Participants
35 neonates
Exposure
Genotype groups vs treatment response
Outcome
Association between genotype and treatment response (diazoxide alone, combination medical therapy, or pancreatectomy)
Methodological detailssingle-centre, tertiary pediatric referral center, Sept 2023 to Sept 2024, 2 patients without pathogenic/likely pathogenic variants excluded
  • Single-centre
  • Tertiary pediatric referral center
  • Sept 2023 to Sept 2024
  • 2 patients without pathogenic/likely pathogenic variants excluded

Main finding

As reported in the abstract

Significant association between genotype and treatment response
p = 0.026

Observational data: associations, not effects.

Further findings

Treatment response, whole cohort

Diazoxide monotherapy effective
60.6% (20/33)
Required diazoxide + octreotide
18.2% (6/33)
Refractory to medical treatment, required surgery
21.2% (7/33)

Most frequent variants

Pathogenic/likely pathogenic variants most frequent in ABCC8 and HK1

Original publication

Genotype-Treatment Correlations in Iranian Children with Congenital Hyperinsulinism: A Single-Center Cohort Study. Horm Res Paediatr. Published 16 June 2026. doi:10.1159/000553031

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.